Relay Therapeutics, Inc. (RLAY) Financials
RLAY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 844.0 million | 92.0 million |
2023-09-30 | 907.0 million | 128.6 million |
2023-06-30 | 962.0 million | 151.9 million |
2023-03-31 | 1.0 billion | 154.1 million |
RLAY Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -89.3 million | 19.3 million |
2023-09-30 | -76.0 million | 21.8 million |
2023-06-30 | -70.1 million | 23.4 million |
2023-03-31 | -69.0 million | 21.5 million |
RLAY Net Income
No data available :(
RLAY Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 750.1 million | - | 53.5 million |
2023-09-30 | 810.6 million | - | 54.6 million |
2023-06-30 | 871.6 million | - | 55.7 million |
2023-03-31 | 937.8 million | - | 56.7 million |
RLAY Shares Outstanding
RLAY Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 118000 | 77.5 million | 16.8 million | - |
2023-09-30 | 590000 | 81.5 million | 18.5 million | - |
2023-06-30 | 1.5 million | 88.2 million | 20.1 million | - |
2023-03-31 | 1.9 million | 82.8 million | 19.6 million | - |
RLAY Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | -1000 | 1.4 million |
2023-09-30 | 25.2 million | 1.4 million |
2023-06-30 | 119000 | 1.3 million |
2023-03-31 | 226000 | 1.2 million |
RLAY
Price: $7.04
52 week price:
Earnings Per Share: -2.79 USD
P/E Ratio: -3.37
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.4 million
Market Capitalization: 934.5 million